Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Statistics

Total Valuation

ARTV has a market cap or net worth of $121.50 million. The enterprise value is $10.22 million.

Market Cap	121.50M
Enterprise Value	10.22M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ARTV has 24.54 million shares outstanding. The number of shares has increased by 354.77% in one year.

Current Share Class	24.54M
Shares Outstanding	24.54M
Shares Change (YoY)	+354.77%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	6.47%
Owned by Institutions (%)	17.95%
Float	4.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.94
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.65, with a Debt / Equity ratio of 0.09.

Current Ratio	11.65
Quick Ratio	11.14
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -47.96% and return on invested capital (ROIC) is -30.17%.

Return on Equity (ROE)	-47.96%
Return on Assets (ROA)	-28.76%
Return on Invested Capital (ROIC)	-30.17%
Return on Capital Employed (ROCE)	-62.54%
Revenue Per Employee	n/a
Profits Per Employee	-$889,753
Employee Count	89
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.99% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-29.99%
50-Day Moving Average	4.02
200-Day Moving Average	2.98
Relative Strength Index (RSI)	58.95
Average Volume (20 Days)	214,193

Short Selling Information

The latest short interest is 391,100, so 1.59% of the outstanding shares have been sold short.

Short Interest	391,100
Short Previous Month	178,188
Short % of Shares Out	1.59%
Short % of Float	8.55%
Short Ratio (days to cover)	0.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-86.15M
Pretax Income	-79.19M
Net Income	-79.19M
EBITDA	-83.60M
EBIT	-86.15M
Earnings Per Share (EPS)	-$3.25

Balance Sheet

The company has $122.97 million in cash and $11.69 million in debt, with a net cash position of $111.28 million or $4.53 per share.

Cash & Cash Equivalents	122.97M
Total Debt	11.69M
Net Cash	111.28M
Net Cash Per Share	$4.53
Equity (Book Value)	129.22M
Book Value Per Share	5.26
Working Capital	118.41M

Cash Flow

In the last 12 months, operating cash flow was -$76.68 million and capital expenditures -$2.23 million, giving a free cash flow of -$78.91 million.

Operating Cash Flow	-76.68M
Capital Expenditures	-2.23M
Free Cash Flow	-78.91M
FCF Per Share	-$3.21

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARTV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-354.77%
Shareholder Yield	-354.77%
Earnings Yield	-65.18%
FCF Yield	-64.94%

Analyst Forecast

The average price target for ARTV is $19.20, which is 287.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.20
Price Target Difference	287.88%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	190.13%
EPS Growth Forecast (5Y)	-27.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ARTV has an Altman Z-Score of 0.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.27
Piotroski F-Score	2